TREGING Trademark

Trademark Overview


On Friday, September 11, 2020, a trademark application was filed for TREGING with the United States Patent and Trademark Office. The USPTO has given the TREGING trademark a serial number of 90175258. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Monday, August 21, 2023. This trademark is owned by TeraImmune, Inc.. The TREGING trademark is filed in the Pharmaceutical Products, Treatment & Processing of Materials Services, Computer & Software Services & Scientific Services, and Medical & Beauty Services & Agricultural Services categories with the following description:

Custom manufacturing services for pharmaceutical products; providing technical information in the field of pharmaceutical manufacturing; custom manufacturing of pharmaceuticals

Pharmaceutical preparations for the treatment of autoimmune diseases and conditions; pharmaceutical preparations for the treatment of hemophilia; pharmaceutical preparations for the treatment of cancer and tumors; pharmaceutical preparations for the treatment of multiple sclerosis, atopic dermatitis, anti-drug antibody formation and xenotransplantation; pharmaceutical preparations for use in immunotherapy, namely, regulatory t-cell therapy

Providing medical information in the field of pharmaceuticals, autoimmune diseases and conditions, hemophilia, cancer, multiple sclerosis, atopic dermatitis, anti-drug antibody formation and xenotransplantation; providing a website featuring medical information in the field of pharmaceuticals, autoimmune diseases and conditions, hemophilia, cancer, multiple sclerosis, atopic dermatitis, anti-drug antibody formation and xenotransplantation; medical consulting in the field of pharmaceuticals, autoimmune diseases and conditions, hemophilia, cancer, multiple sclerosis, atopic dermatitis, anti-drug antibody formation and xenotransplantation; medical services; veterinary services; medical services in the extraction of human and animal cells from patients; manipulation of human and animal cells for therapeutic purposes; reinsertion of cells into human and animal patients for medical purposes; providing medical and therapy advice and consultancy in the field of medical and veterinary therapies...

Medical and pharmaceutical research and development services; scientific research and development services in the medical field; providing medical and scientific research information in the medical field; providing medical and scientific research information in the field of pharmaceuticals and clinical trials; providing medical and scientific research information relating to diagnostic, prophylactic and therapeutic properties of pharmaceuticals; scientific research and development services in the field of regulatory t-cell and chimeric antigen receptor therapy; scientific research and development services in the field of new cancer therapies; medical and veterinary research services, namely, the manipulation of cells within a laboratory or research facility to enable the cells to be used for therapeutic purposes; scientific research in human and animal gene therapy; scientific research into vectors and preparations for manipulating and adapting human and animal cells; scientific and me...
treging

General Information


Serial Number90175258
Word MarkTREGING
Filing DateFriday, September 11, 2020
Status606 - ABANDONED - NO STATEMENT OF USE FILED
Status DateMonday, August 21, 2023
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, May 25, 2021

Trademark Statements


Goods and ServicesCustom manufacturing services for pharmaceutical products; providing technical information in the field of pharmaceutical manufacturing; custom manufacturing of pharmaceuticals
Goods and ServicesPharmaceutical preparations for the treatment of autoimmune diseases and conditions; pharmaceutical preparations for the treatment of hemophilia; pharmaceutical preparations for the treatment of cancer and tumors; pharmaceutical preparations for the treatment of multiple sclerosis, atopic dermatitis, anti-drug antibody formation and xenotransplantation; pharmaceutical preparations for use in immunotherapy, namely, regulatory t-cell therapy
Goods and ServicesProviding medical information in the field of pharmaceuticals, autoimmune diseases and conditions, hemophilia, cancer, multiple sclerosis, atopic dermatitis, anti-drug antibody formation and xenotransplantation; providing a website featuring medical information in the field of pharmaceuticals, autoimmune diseases and conditions, hemophilia, cancer, multiple sclerosis, atopic dermatitis, anti-drug antibody formation and xenotransplantation; medical consulting in the field of pharmaceuticals, autoimmune diseases and conditions, hemophilia, cancer, multiple sclerosis, atopic dermatitis, anti-drug antibody formation and xenotransplantation; medical services; veterinary services; medical services in the extraction of human and animal cells from patients; manipulation of human and animal cells for therapeutic purposes; reinsertion of cells into human and animal patients for medical purposes; providing medical and therapy advice and consultancy in the field of medical and veterinary therapies; providing cancer therapy advice and consultancy
Goods and ServicesMedical and pharmaceutical research and development services; scientific research and development services in the medical field; providing medical and scientific research information in the medical field; providing medical and scientific research information in the field of pharmaceuticals and clinical trials; providing medical and scientific research information relating to diagnostic, prophylactic and therapeutic properties of pharmaceuticals; scientific research and development services in the field of regulatory t-cell and chimeric antigen receptor therapy; scientific research and development services in the field of new cancer therapies; medical and veterinary research services, namely, the manipulation of cells within a laboratory or research facility to enable the cells to be used for therapeutic purposes; scientific research in human and animal gene therapy; scientific research into vectors and preparations for manipulating and adapting human and animal cells; scientific and medical research consultancy relating to all the aforesaid services

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateTuesday, October 20, 2020
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

International Class040 - Treatment of materials.
US Class Codes100, 103, 106
Class Status Code6 - Active
Class Status DateTuesday, October 20, 2020
Primary Code040
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateTuesday, October 20, 2020
Primary Code042
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

International Class044 - Medical services; veterinary services; hygienic and beauty care for human beings or animals; agriculture, horticulture and forestry services.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateTuesday, October 20, 2020
Primary Code044
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameBOUNCE MERGER SUB II, LLC
Party Type21 - New Owner After Publication
Legal Entity Type16 - Limited Liability Company
AddressMALVERN, PA 19355

Party NameTeraImmune, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressGaithersburg, MD 20878

Party NameTeraImmune, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressGaithersburg, MD 20878

Trademark Events


Event DateEvent Description
Thursday, October 5, 2023TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
Thursday, October 5, 2023TEAS CHANGE OF CORRESPONDENCE RECEIVED
Thursday, October 5, 2023ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Thursday, October 5, 2023TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Thursday, October 5, 2023APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Thursday, October 5, 2023TEAS CHANGE OF OWNER ADDRESS RECEIVED
Monday, August 21, 2023ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
Monday, August 21, 2023ABANDONMENT - NO USE STATEMENT FILED
Wednesday, July 26, 2023AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
Friday, December 23, 2022NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, December 21, 2022SOU EXTENSION 3 GRANTED
Wednesday, December 21, 2022SOU EXTENSION 3 FILED
Wednesday, December 21, 2022SOU TEAS EXTENSION RECEIVED
Saturday, July 16, 2022NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, July 14, 2022SOU EXTENSION 2 GRANTED
Thursday, July 14, 2022SOU EXTENSION 2 FILED
Thursday, July 14, 2022SOU TEAS EXTENSION RECEIVED
Friday, April 15, 2022TEAS CHANGE OF CORRESPONDENCE RECEIVED
Friday, April 15, 2022ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Friday, April 15, 2022TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Saturday, January 15, 2022NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, January 13, 2022SOU EXTENSION 1 GRANTED
Thursday, January 13, 2022SOU EXTENSION 1 FILED
Thursday, January 13, 2022SOU TEAS EXTENSION RECEIVED
Tuesday, July 20, 2021NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, May 25, 2021OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, May 25, 2021PUBLISHED FOR OPPOSITION
Wednesday, May 5, 2021NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Sunday, April 18, 2021APPROVED FOR PUB - PRINCIPAL REGISTER
Friday, April 16, 2021TEAS/EMAIL CORRESPONDENCE ENTERED
Friday, April 16, 2021CORRESPONDENCE RECEIVED IN LAW OFFICE
Friday, April 16, 2021TEAS RESPONSE TO OFFICE ACTION RECEIVED
Friday, January 29, 2021NOTIFICATION OF NON-FINAL ACTION E-MAILED
Friday, January 29, 2021NON-FINAL ACTION E-MAILED
Friday, January 29, 2021NON-FINAL ACTION WRITTEN
Thursday, January 21, 2021ASSIGNED TO EXAMINER
Tuesday, October 20, 2020NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Tuesday, September 15, 2020NEW APPLICATION ENTERED